Avalo Therapeutics, Inc.
AVTX
59 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 18 8:10 PM | Christopher Ryan SullivanChief Financial Officer | Sale | 12,394 | $16.33 | $202.4K | 39,900(D) | View → |
| Sep 10, 2026 | Sep 11 8:10 PM | Christopher Ryan SullivanChief Financial Officer | Sale | 10,185 | $17.62 | $179.5K | 39,900(D) | View → |
| Aug 28, 2026 | Sep 1 8:38 PM | Mittie DoyleChief Medical Officer | Sale | 679 | $20.00 | $13.6K | 51,776(D) | View → |
| Aug 18, 2026 | Aug 19 8:10 PM | Christopher Ryan SullivanChief Financial Officer | Sale | 31,031 | $20.05 | $622.3K | 39,900(D) | View → |
| Aug 17, 2026 | Aug 19 8:10 PM | Christopher Ryan SullivanChief Financial Officer | Sale | 41,694 | $19.86 | $828.1K | 39,900(D) | View → |
| Aug 17, 2026 | Aug 19 8:10 PM | Mittie DoyleChief Medical Officer | Sale | 1,000 | $20.00 | $20.0K | 51,776(D) | View → |
| Aug 18, 2026 | Aug 18 8:18 PM | CHRISTOPHER RYAN SULLIVAN | Proposed Sale | 31,031 | $20.05 | $622.2K | — | View → |
| Aug 17, 2026 | Aug 17 8:49 PM | MITTIE DOYLE | Proposed Sale | 5,037 | $19.59 | $98.7K | — | View → |
| Aug 17, 2026 | Aug 17 8:47 PM | CHRISTOPHER RYAN SULLIVAN | Proposed Sale | 70,709 | $19.59 | $1.4M | — | View → |
| Aug 17, 2026 | Aug 17 8:18 PM | CHRISTOPHER RYAN SULLIVAN | Proposed Sale | 3,749 | $19.94 | $74.8K | — | View → |
| Aug 11, 2026 | Aug 12 8:10 PM | Jennifer RileyChief Strategy Officer | Sale | 2,655 | $19.59 | $52.0K | 37,041(D) | View → |
| Aug 10, 2026 | Aug 12 8:10 PM | Mittie DoyleChief Medical Officer | Sale | 679 | $20.00 | $13.6K | 51,776(D) | View → |
| Aug 11, 2026 | Aug 11 8:22 PM | JENNIFER RILEY | Proposed Sale | 2,655 | $19.59 | $52.0K | — | View → |
| Aug 10, 2026 | Aug 10 8:47 PM | MITTIE DOYLE | Proposed Sale | 679 | $18.32 | $12.4K | — | View → |
| Jul 27, 2026 | Jul 29 8:05 PM | Mittie DoyleChief Medical Officer | Sale | 1,000 | $20.00 | $20.0K | 51,776(D) | View → |
| Jun 30, 2026 | Jul 2 8:05 PM | Mittie DoyleChief Medical Officer | Sale | 4,654 | $20.00 | $93.1K | 51,776(D) | View → |
| Jun 23, 2026 | Jun 25 9:24 PM | Mittie DoyleChief Medical Officer | Sale | 1,450 | $18.00 | $26.1K | 51,776(D) | View → |
| Jun 2, 2026 | Jun 2 8:08 PM | JONATHAN GOLDMAN | Proposed Sale | 42,833 | $14.39 | $616.2K | — | View → |
| May 28, 2026 | Jun 1 8:05 PM | Mittie DoyleChief Medical Officer | Sale | 679 | $16.00 | $10.9K | 47,122(D) | View → |
| May 15, 2026 | May 19 8:10 PM | Mittie DoyleChief Medical Officer | Sale | 3,000 | $18.76 | $56.3K | 3,622(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 28, 2026 | Mar 31 8:09 PM | Jonathan GoldmanDirector | Option Exercise | 3,166 | — | 3,167(D) | View → |
| Mar 16, 2026 | Mar 18 8:07 PM | Mittie DoyleChief Medical Officer | Option Exercise | 25,492 | $12.65 | 149,008(D) | View → |
| Feb 26, 2026 | Mar 2 9:24 PM | Paul VarkiChief Legal Officer | Grant/Award | 80,000 | $17.64 | 80,000(D) | View → |
| Feb 26, 2026 | Mar 2 9:23 PM | Jennifer RileyChief Strategy Officer | Grant/Award | 95,000 | $17.64 | 95,000(D) | View → |
| Feb 26, 2026 | Mar 2 9:23 PM | Mittie DoyleChief Medical Officer | Grant/Award | 105,000 | $17.64 | 105,000(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | Taylor BoydChief Business Officer | Grant/Award | 95,000 | $17.64 | 95,000(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | Christopher Ryan SullivanChief Financial Officer | Grant/Award | 105,000 | $17.64 | 105,000(D) | View → |
| Feb 26, 2026 | Mar 2 9:20 PM | Garry Arthur NeilDirector, Chief Executive Officer | Grant/Award | 286,000 | $17.64 | 286,000(D) | View → |
← Previous
Page 3 of 3